Please enable JavaScript to continue using this application.

Compare $BNTC vs $LRMR | Chartloom

Compare

$BNTC vs $LRMR

Benitec Biopharma Inc · Larimar Therapeutics Inc

BNTC

Benitec Biopharma Inc

LRMR

Larimar Therapeutics Inc

Compare $BNTC vs $LRMR

Comparing Benitec Biopharma Inc and Larimar Therapeutics Inc

BNTCBenitec Biopharma Inc

LRMRLarimar Therapeutics Inc

BNTCBenitec Biopharma Inc

Market cap

$305M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-29.5%

52W performance

-37.1%

FCF yield

-5.5%

LRMRLarimar Therapeutics Inc

Market cap

$277M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-23.1%

52W performance

-44.6%

FCF yield

-56.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BNTC

LRMR

Detailed metrics comparison

BNTC

Benitec Biopharma Inc

LRMR

Larimar Therapeutics Inc

Market Cap

BNTC$305M

LRMR$277M

Enterprise Value

BNTC$125M

LRMR$185M

Price

BNTC$8.87

LRMR$2.67

P/E Ratio

BNTCN/A

LRMRN/A

P/S Ratio

BNTC4,474.96x

LRMR0.00x

EV/Sales

BNTC1,903.93x

LRMR0.00x

EV/EBITDA

BNTC0.00x

LRMR0.00x

P/B Ratio

BNTC1.77x

LRMR2.41x

P/FCF Ratio

BNTCN/A

LRMRN/A

EV/FCF

BNTC-7.50x

LRMR-1.18x

PEG Ratio

BNTCN/A

LRMRN/A

Forward P/E (NTM)

BNTCN/A

LRMRN/A

Forward P/S (NTM)

BNTCN/A

LRMRN/A

Revenue (TTM)

BNTC$0

LRMR$0

Revenue Growth (YoY)

BNTCN/A

LRMRN/A

Forward Rev Growth

BNTC13.8%

LRMR290.4%

Gross Margin (TTM)

BNTC100.0%

LRMR0.0%

Operating Margin (TTM)

BNTC0.0%

LRMR0.0%

EBITDA Margin (TTM)

BNTC0.0%

LRMR0.0%

Net Margin (TTM)

BNTC0.0%

LRMR0.0%

FCF Margin (TTM)

BNTCN/A

LRMRN/A

Net Income (TTM)

BNTC$-33M

LRMR$-173M

FCF (TTM)

BNTC$-17M

LRMR$-156M

EPS (TTM)

BNTC$0.00

LRMR-$1.66

ROE (TTM)

BNTC-3482.0%

LRMR-13739.0%

ROA (TTM)

BNTC-3411.0%

LRMR-9765.0%

ROIC (TTM)

BNTC-3482.0%

LRMR-13739.0%

Cash

BNTC$180M

LRMR$93M

Debt

BNTC$0

LRMR$0

Net Cash/Debt

BNTC$180M

LRMR$93M

Current Ratio (TTM)

BNTC34.00x

LRMR4.70x

Quick Ratio (TTM)

BNTC33.70x

LRMR4.58x

Debt/Equity (TTM)

BNTC0.00x

LRMR0.00x

Debt/Assets (TTM)

BNTC0.0%

LRMR0.0%

Interest Coverage (TTM)

BNTCN/A

LRMRN/A

Net Debt/EBITDA (TTM)

BNTC0.00x

LRMR0.00x

Beta

BNTC0.23

LRMR0.68

52W Performance

BNTC-37.1%

LRMR-44.6%

YTD Performance

BNTC-29.5%

LRMR-23.1%

% from 52W High

BNTC-47.1%

LRMR-58.4%

% from 52W Low

BNTC4.1%

LRMR2.3%

Asset Turnover (TTM)

BNTC0.01x

LRMR0.00x

FCF Yield (TTM)

BNTC-5.5%

LRMR-56.3%

Earnings Yield (TTM)

BNTC-10.7%

LRMR-62.2%

Dividend Yield (TTM)

BNTCN/A

LRMRN/A

Rule of 40

BNTC0.0

LRMR0.0

EV/GP/RG

BNTCN/A

LRMRN/A

Ticker research

View BNTC research View LRMR research

Metric	BNTC Benitec Biopharma Inc	LRMR Larimar Therapeutics Inc
Market & Valuation
Market Cap	$305M	$277M
Enterprise Value	$125M	$185M
Price	$8.87	$2.67
P/E Ratio	N/A	N/A
P/S Ratio	4,474.96x	0.00x
EV/Sales	1,903.93x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.77x	2.41x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-1.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	13.8%	290.4%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-173M
FCF (TTM)	$-17M	$-156M
EPS (TTM)	$0.00	-$1.66
ROE (TTM)	-3482.0%	-13739.0%
ROA (TTM)	-3411.0%	-9765.0%
ROIC (TTM)	-3482.0%	-13739.0%
Financial Health
Cash	$180M	$93M
Debt	$0	$0
Net Cash/Debt	$180M	$93M
Current Ratio (TTM)	34.00x	4.70x
Quick Ratio (TTM)	33.70x	4.58x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	0.68
52W Performance	-37.1%	-44.6%
YTD Performance	-29.5%	-23.1%
% from 52W High	-47.1%	-58.4%
% from 52W Low	4.1%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-5.5%	-56.3%
Earnings Yield (TTM)	-10.7%	-62.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BNTC research	View LRMR research

Valuation

P/S Ratio

LRMR

0.00x

BNTC

4,474.96x

EV/FCF

BNTC

-7.50x

LRMR

-1.18x

Growth & revenue

Forward Revenue Growth

LRMR

290.4%

BNTC

13.8%

Profitability & performance

Gross Margin

BNTC

100.0%

LRMR

0.0%

ROE

BNTC

-3482.0%

LRMR

-13739.0%

FCF Yield %

BNTC

-5.5%

LRMR

-56.3%

52-Week Performance

BNTC

-37.1%

LRMR

-44.6%

Detailed metrics comparison

BNTC

Benitec Biopharma Inc

LRMR

Larimar Therapeutics Inc

Market Cap

BNTC$305M

LRMR$277M

Enterprise Value

BNTC$125M

LRMR$185M

Price

BNTC$8.87

LRMR$2.67

P/E Ratio

BNTCN/A

LRMRN/A

P/S Ratio

BNTC4,474.96x

LRMR0.00x

EV/Sales

BNTC1,903.93x

LRMR0.00x

EV/EBITDA

BNTC0.00x

LRMR0.00x

P/B Ratio

BNTC1.77x

LRMR2.41x

P/FCF Ratio

BNTCN/A

LRMRN/A

EV/FCF

BNTC-7.50x

LRMR-1.18x

PEG Ratio

BNTCN/A

LRMRN/A

Forward P/E (NTM)

BNTCN/A

LRMRN/A

Forward P/S (NTM)

BNTCN/A

LRMRN/A

Revenue (TTM)

BNTC$0

LRMR$0

Revenue Growth (YoY)

BNTCN/A

LRMRN/A

Forward Rev Growth

BNTC13.8%

LRMR290.4%

Gross Margin (TTM)

BNTC100.0%

LRMR0.0%

Operating Margin (TTM)

BNTC0.0%

LRMR0.0%

EBITDA Margin (TTM)

BNTC0.0%

LRMR0.0%

Net Margin (TTM)

BNTC0.0%

LRMR0.0%

FCF Margin (TTM)

BNTCN/A

LRMRN/A

Net Income (TTM)

BNTC$-33M

LRMR$-173M

FCF (TTM)

BNTC$-17M

LRMR$-156M

EPS (TTM)

BNTC$0.00

LRMR-$1.66

ROE (TTM)

BNTC-3482.0%

LRMR-13739.0%

ROA (TTM)

BNTC-3411.0%

LRMR-9765.0%

ROIC (TTM)

BNTC-3482.0%

LRMR-13739.0%

Cash

BNTC$180M

LRMR$93M

Debt

BNTC$0

LRMR$0

Net Cash/Debt

BNTC$180M

LRMR$93M

Current Ratio (TTM)

BNTC34.00x

LRMR4.70x

Quick Ratio (TTM)

BNTC33.70x

LRMR4.58x

Debt/Equity (TTM)

BNTC0.00x

LRMR0.00x

Debt/Assets (TTM)

BNTC0.0%

LRMR0.0%

Interest Coverage (TTM)

BNTCN/A

LRMRN/A

Net Debt/EBITDA (TTM)

BNTC0.00x

LRMR0.00x

Beta

BNTC0.23

LRMR0.68

52W Performance

BNTC-37.1%

LRMR-44.6%

YTD Performance

BNTC-29.5%

LRMR-23.1%

% from 52W High

BNTC-47.1%

LRMR-58.4%

% from 52W Low

BNTC4.1%

LRMR2.3%

Asset Turnover (TTM)

BNTC0.01x

LRMR0.00x

FCF Yield (TTM)

BNTC-5.5%

LRMR-56.3%

Earnings Yield (TTM)

BNTC-10.7%

LRMR-62.2%

Dividend Yield (TTM)

BNTCN/A

LRMRN/A

Rule of 40

BNTC0.0

LRMR0.0

EV/GP/RG

BNTCN/A

LRMRN/A

Ticker research

View BNTC research View LRMR research

Metric	BNTC Benitec Biopharma Inc	LRMR Larimar Therapeutics Inc
Market & Valuation
Market Cap	$305M	$277M
Enterprise Value	$125M	$185M
Price	$8.87	$2.67
P/E Ratio	N/A	N/A
P/S Ratio	4,474.96x	0.00x
EV/Sales	1,903.93x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.77x	2.41x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-1.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	13.8%	290.4%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-173M
FCF (TTM)	$-17M	$-156M
EPS (TTM)	$0.00	-$1.66
ROE (TTM)	-3482.0%	-13739.0%
ROA (TTM)	-3411.0%	-9765.0%
ROIC (TTM)	-3482.0%	-13739.0%
Financial Health
Cash	$180M	$93M
Debt	$0	$0
Net Cash/Debt	$180M	$93M
Current Ratio (TTM)	34.00x	4.70x
Quick Ratio (TTM)	33.70x	4.58x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	0.68
52W Performance	-37.1%	-44.6%
YTD Performance	-29.5%	-23.1%
% from 52W High	-47.1%	-58.4%
% from 52W Low	4.1%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-5.5%	-56.3%
Earnings Yield (TTM)	-10.7%	-62.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BNTC research	View LRMR research